Cash & equivalents increased 628.0%
Cash & equivalents changed +628.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +628.0% from the comparable as-filed period.
Debt changed -74.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross margin changed +5867 basis points from the comparable as-filed period.
Gross profit changed +270.7% from the comparable as-filed period.
Inventory changed +45.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed +57.8% from the comparable as-filed period.
Operating income changed +76.0% from the comparable as-filed period.
Operating margin changed +12992 basis points from the comparable as-filed period.
Research & development changed +629.5% from the comparable as-filed period.
Revenue changed +89.6% from the comparable as-filed period.
Selling, general & administrative changed -22.7% from the comparable as-filed period.
Stock-based compensation changed -88.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.